Your organization needs to know what demand fluctuations to expect, including shortages and competitor interruptions.

It can take several weeks to months to ramp up production to address the market gap due to drug shortages. This makes for an uncertain market, as manufacturers cannot predict which products will be in short supply or how long the shortage will last.

 

Manufacturers need to respond proactively to supply uncertainty; USP Medicine Supply Map Insights can provide the essential data needed.

 

"The USP Medicine Supply Map is helping us identify upstream vulnerabilities in the supply chain for various essential medicines and determine those where Phlow’s capabilities in advanced manufacturing, can have the biggest impact,” said Dave Levin, M.D., Chief Medical and Information Officer of Phlow Corp.1

Medicine Supply Map Insights can help your organization diversify its active pharmaceutical ingredients (API) supply.

  • Over 80% of United States active pharmaceutical ingredients (APIs) and drug product manufacturers' locations are identified within the data.
  • API manufacturers are traced for 40% of US Rx labels.
  • Medicine Supply Map Insights is updated on a monthly basis, so your organization can remain informed on the impacts of drug shortages.

 

1. United States Pharmacopeia. (2021 March 16). U.S. Pharmacopeia Medicine Supply Map releases global API manufacturing findings [Press release]. https://www.usp.org/news/medicine-supply-map-releases-global-api-manufacturing-findings

 

Make better product planning decisions with USP Medicine Supply Map Insights. Apply to become an early user and receive a sample data set.

 

 

Application does not guarantee acceptance into the early user program. By providing your contact information to USP,  you consent to be contacted by USP. You may opt out at any time by following the instructions included in every email alert sent to you by USP. You further agree to terms of USP’s Privacy Policy.